UCSF COVID-19 Vaccine Information Hub

Updated July 12, 2021

With an ample supply of COVID-19 vaccines on hand, UCSF continues to vaccinate its employees, learners, patients and the public.

Drop-in COVID-19 Vaccination Sites

UCSF is offering more drop-in sites where employees and learners can get safe, free and effective COVID-19 vaccines. People may just walk into these locations or schedule an appointment by calling (415) 476-3307. Here are the locations:

  • Parnassus Heights campus: 505 Parnassus Avenue, Moffitt Hospital, Park Room M 286, Tuesdays, from 12:30 to 5:30 p.m. and Fridays, from 7 a.m. to 2:30 p.m.
  • Mount Zion: 2356 Sutter Street, Ida’s Café, first floor, Wednesdays, from 8 a.m. to 12 p.m.
  • Mission Bay campus: 1825 4th Street, fourth floor, Mondays (starting Aug. 2, 2021) and Thursdays, from 8 a.m. to 12 p.m.
    • Rutter Building, 1675 Owens Street, Student Health Services, Third Floor, Room 330, Wednesdays from July 21 through September 29, from 7 a.m. to 1 p.m.


This dashboard provides an overview of the COVID-19 vaccination rollout at UCSF. It includes metrics on vaccination counts and rates for patients, employees, and community healthcare workers (HCW) who were vaccinated by UCSF.

Key definitions for data on this dashboard:

  • Cumulative Persons Vaccinated: persons who have received at least one dose
  • Persons Fully Vaccinated: persons who have completed either the single-dose or two-dose regimen 

For keyboard accessibility command help with Tableau dashboards, click here.



Vaccine Guidance


Vaccine Facts and Resources

Vaccines Approved for Use in the U.S.

The table below summarizes what’s known and not yet known about each of the COVID-19 vaccines that have been granted Emergency Use Authorization from the U.S Food and Drug Administration.

  Pfizer Moderna Johnson & Johnson
Date Vaccine Authorized by FDA Dec. 11, 2020 Dec. 18, 2020 Feb. 27, 2021
Vaccine Technology mRNA vaccine mRNA vaccine Modified adenovirus
Populations Authorized for Vaccination People age 16 and older People age 18 and older People age 18 and older
Number of Doses Required 2 2 1
Days Between First and Second Dose 21 28 n/a
Peak Efficacy 95% effective at preventing symptomatic disease 94.1% effective at preventing symptomatic disease 85% effective at preventing severe disease*
When Peak Efficacy is Reached 7 days after Dose #2 7 days after Dose #2 28 days after vaccination
How Long Immunity Lasts TBD TBD TBD

*The clinical trials for the Johnson & Johnson vaccine assessed different COVID-19 symptoms and were conducted at different times during the pandemic. All three vaccines were found to be effective in reducing or preventing severe disease, hospitalization and death from COVID-19.


Frequently Asked Questions

If you are a UCSF patient, find more FAQs on the Patient Hub.

More vaccine questions? Email [email protected]